Nephros NEPH
NASDAQ NEPH
$3.31 +0.24 (+7.82%)
At close: Nov 12, 2026 · 4:00 PM EST

Nephros (NEPH) Sale and Maturity of Investments (2009)

Updated

Analysis

Nephros (NEPH) Sale and Maturity of Investments (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn -
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn -
3 Danaher 163.29 Bn 142.96 Bn 3.84 Bn -
4 Intuitive Surgical 152.47 Bn 132.89 Bn 2.08 Bn 2.11 Bn
5 Medtronic 131.95 Bn 97.47 Bn 6.34 Bn 2.21 Bn
6 Stryker 119.59 Bn 105.78 Bn 4.25 Bn 89.00 Mn
7 Boston Scientific 64.18 Bn 59.61 Bn 3.43 Bn 27.00 Mn
8 Edwards Lifesciences 60.93 Bn 44.24 Bn 1.35 Bn 492.50 Mn
9 Medline 52.61 Bn 49.74 Bn 1.93 Bn -
10 Nephros 35.98 Mn 17.32 Mn 3.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2009 7,000.00
API Access

Nephros Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NEPH&period=max&api_key=YOUR_API_KEY